点击上方 一键预约最新最热的医药健康新闻政策近期,全球制药圈的财报分析群里弥漫着一股“格局碎了”的震撼。起因是2025年全球制药巨头年报集体揭晓——这份本该是年度常规“成绩单”的文件,却像一颗投入湖面的深水炸弹,炸出了行业格局的剧烈震荡:既有新王踩着GLP-1浪潮登顶的颠覆性突破,也有老牌豪强因单一爆品折戟的意外滑落,更有代谢赛道与肿瘤正式分庭抗礼的20年最大权力转移。最戳行业神经的几个“名场面”...
Source Link点击上方 一键预约最新最热的医药健康新闻政策近期,全球制药圈的财报分析群里弥漫着一股“格局碎了”的震撼。起因是2025年全球制药巨头年报集体揭晓——这份本该是年度常规“成绩单”的文件,却像一颗投入湖面的深水炸弹,炸出了行业格局的剧烈震荡:既有新王踩着GLP-1浪潮登顶的颠覆性突破,也有老牌豪强因单一爆品折戟的意外滑落,更有代谢赛道与肿瘤正式分庭抗礼的20年最大权力转移。最戳行业神经的几个“名场面”...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.